Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Syed Naqvi

Concepts (45)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Syed Naqvi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Syed Naqvi has written about over time.
Genomics, 1 publications between 2017 and 2017, average publication date June 2017. Immunoglobulin Heavy Chains, 1 publications between 2017 and 2017, average publication date June 2017. Immunoglobulin Variable Region, 1 publications between 2017 and 2017, average publication date June 2017. Leukemia, Lymphocytic, Chronic, B-Cell, 1 publications between 2017 and 2017, average publication date June 2017. Oncolytic Virotherapy, 1 publications between 2021 and 2021, average publication date October 2021. Melanoma, 4 publications between 2020 and 2024, average publication date February 2022. Skin Neoplasms, 4 publications between 2020 and 2024, average publication date February 2022. Melphalan, 2 publications between 2020 and 2024, average publication date September 2022. Aged, 80 and over, 5 publications between 2017 and 2024, average publication date September 2022. Antineoplastic Combined Chemotherapy Protocols, 3 publications between 2020 and 2024, average publication date May 2023. Chemotherapy, Cancer, Regional Perfusion, 3 publications between 2020 and 2024, average publication date May 2023. Extremities, 3 publications between 2020 and 2024, average publication date May 2023. Dactinomycin, 1 publications between 2024 and 2024, average publication date September 2024. Sarcoma, 1 publications between 2024 and 2024, average publication date September 2024. Antibodies, Monoclonal, 1 publications between 2024 and 2024, average publication date October 2024. Antibodies, Monoclonal, Humanized, 1 publications between 2024 and 2024, average publication date October 2024. Lung Neoplasms, 1 publications between 2024 and 2024, average publication date October 2024. Small Cell Lung Carcinoma, 1 publications between 2024 and 2024, average publication date October 2024.

To see the data from this visualization as text, click here.
Naqvi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description